U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 212379
Company: JOURNEY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
AMZEEQ MINOCYCLINE HYDROCHLORIDE EQ 4% BASE AEROSOL, FOAM;TOPICAL Prescription None Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/18/2019 ORIG-1 Approval Type 3 - New Dosage Form STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212379s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/212379Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212379Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/13/2022 SUPPL-7 Manufacturing (CMC)-Expiration Date Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212379Orig1s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/212379Orig1s007ltr.pdf
01/29/2021 SUPPL-3 Labeling-Package Insert, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212379s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/212379Orig1s003ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
01/13/2022 SUPPL-7 Manufacturing (CMC)-Expiration Date Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212379Orig1s007lbl.pdf
01/29/2021 SUPPL-3 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212379s003lbl.pdf
01/29/2021 SUPPL-3 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212379s003lbl.pdf
10/18/2019 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212379s000lbl.pdf
Back to Top